In February, the World Health Organization (WHO) published their first list of antibiotic-resistant “priority pathogens”. This is a list of the most concerning bacteria that pose the “greatest threat to human health”. This list is divided into three levels of antibiotic-resistant bacteria based on their significance and potential impact to global health. The priority levels are listed as Priority 1 ‘Critical’, Priority 2 ‘High’ and Priority 3 ‘Medium’. Priority 1 (or ‘Critical’) is the most worrisome.
<span style="color:red; font weight:bold">Goodbye Winter. Hello Spring!:</span><p>
When someone is acutely ill, he/she relies on hospitals with trained professionals and employees to treat or alleviate their symptoms and/or illness(es). The patient puts his/her faith and trust in the healthcare facility and workers to take care of the problem, not add to it.
Chlorhexidine Gluconate for the Prevention of Central Line-Associated Bloodstream Infections - Current Science
A recent article entitled Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine published in the Antimicrobial Agents and Chemotherapy journal showed how researchers induced resistance to chlorhexidine (CHG) in Klebsiella pneumoniae, and identified cross-resistance to the antibiotic, colistin—marking the first time that any bacteria was shown to exhibit resistance to CHG.
Thanksgiving Day is only a few weeks away.
What thoughts come to mind?
Perhaps family, friends, travel, turkey with all its trimmings, pumpkin pie, and shopping?
(October 2016) — Celebrating Change in Healthcare and Infection Prevention
(September 2016)—Bacterial Outbreak Highlights the Need for Basic Infection Prevention Measures
Keith St. John joins PDI with a background in clinical microbiology, medical technology, and infectious diseases. For decades, he worked as an Infection Preventionist (IP) and most recently as a Clinical Epidemiologist and IP. Keith has worked in a variety of healthcare settings, including adult, pediatrics, and industry, and holds a certification in Infection control (CIC) and medical technology (ASCP).
Debra Hagberg joins PDI with a background in medical technology, microbiology and infectious diseases. She began her career as a microbiologist, before transitioning into her role as an Infection Preventionist and then to a Director of IP/Quality. Deb has worked in a variety of healthcare settings, including ambulatory, acute rehabilitation, and industry, and holds a certification in infection control (CIC) and medical technology (ASCP).